The Advanced level of the Aleph Product Safety & Performance Testing course track is for professionals who already have the bench-testing and risk-management vocabulary covered at orientation depth and need to develop the applied skills the medical-device and IVD industries expect: conducting applied FMEA and FTA on a chosen device; running the ISO 14971:2019 process end to end; planning non-clinical bench testing aligned with the FDA Safety and Performance Based Pathway and 510(k) expectations; integrating IEC 62366-1 usability engineering, human factors, and IEC 62304 software-risk classification into the safety / performance documentation set; constructing risk matrices and applying the ISO 14971 risk-control hierarchy; critically evaluating post-market surveillance data and the FDA MAUDE and EU MDR vigilance datasets; performing benefit-risk assessment that integrates clinical benefit with residual risk and population-level safety; and authoring a Risk Management File and Risk Management Report and a benefit-risk analysis for a chosen device.

This 32-hour Professional Certificate Course builds directly on the 16-hour Introductory level (`RAQ-532-I`). It does not repeat the bench-testing / safety / risk vocabulary orientation. Where the Introductory level identifies FMEA and FTA, the Advanced level conducts both on the chosen device. Where the Introductory level identifies the FDA Safety and Performance Based Pathway, the Advanced level develops a bench-testing plan aligned with it. The course is organized around a chosen-device cumulative deliverable arc — the participant selects a device in Module 1, builds Risk Management content on it across Modules 2 through 8, and integrates everything into a Risk Management File, Risk Management Report, and benefit-risk analysis in the Module 9 capstone course exercise.

Graduates of the Advanced course are positioned for senior applied work in Design Assurance, Risk Management, Regulatory Affairs, and post-market surveillance roles at medical-device and IVD manufacturers; at test laboratories supporting the bench-testing chain; and at consultancies serving manufacturers on FDA and EU MDR / IVDR submissions. The authored Risk Management File, Risk Management Report, and benefit-risk analysis produced during the course are portfolio-grade artifacts.

Participants who meet the course completion requirements receive a Certificate of Completion issued by Aleph University.